Diabetes drug Actos banned in India
India | Regulatory | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013
Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain...Read more
BIO India to take up vaccine development
India | News | By BioSpectrum Bureau | 0 Comment | 15 Aug, 2012
Mumbai: Recognizing India as a model for the global vaccine market, the Biotechnology Industry Organization (BIO) has pl...Read more
We are going to reduce Injectible Polio Vaccine cost, says Dr Cyrus Poonawalla
India | Influencers | By BioSpectrum Bureau | 4 Comment | 15 Jul, 2013
Pune-based Serum Institute of India (SIIL), one of the largest providers of affordable quality vaccines in the world, ha...Read more
Interphex Japan: Japan pharma eyes China, India
India | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013
Tokyo: The 7th in-Pharma Japan and 26th Interphex Japan, which are being concurrently held at Tokyo Big Sight, Japan, k...Read more
Ranbaxy records 55% sales growth in Q2 2012
India | Company results | By BioSpectrum Bureau | 4 Comment | 13 Aug, 2012
New Delhi: Ranbaxy Laboratories has reported a 55 percent growth in sales revenue in the second quarter of 2012 over the...Read more
Cipla's mother-baby pack wins BioSpectrum award
India | Influencers | By BioSpectrum Bureau | 1 Comment | 15 Mar, 2012
Towards the end of November 2010, Cipla, a Mumbai-based pharmaceutical major, took a step ahead in revolutionizing HIV/A...Read more
Intrexon appoints new VP and CIO
India | News | By BioSpectrum Bureau | 0 Comment | 20 Nov, 2013
Singapore: US-based Intrexon, a synthetic biology company, has appointed Dr Peter Seufer-Wasserthal as VP, business deve...Read more
'Personalized Shipment Service' for cord blood in India
India | News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2012
Bangalore: LifeCell International, India's largest and most accredited stem cell storage company announced its partnersh...Read more
Harvard, MIT clinical research course now in India
India | News | By BioSpectrum Bureau | 0 Comment | 17 Aug, 2012
Mumbai: A new introductory course on clinical research has been introduced at the Harvard School of Public Health (HSPH)...Read more
MSD sues Glenmark for diabetes drug patent
India | News | By BioSpectrum Bureau | 0 Comment | 03 Apr, 2013
New Delhi: The legal battles between pharma MNCs and local drug companies doesn't seem to cease in India. Following the ...Read more
Pharma discusses FDA suggestion on Quality by Design
India | News | By BioSpectrum Bureau | 0 Comment | 01 Oct, 2012
Mumbai: At the recently held, DIA IT Life Sciences Summit 2012, a host of current topics were discussed at length among ...Read more
Daiichi may take legal action against ex-Ranbaxy promoters
India | News | By BioSpectrum Bureau | 0 Comment | 24 May, 2013
Singapore: Breaking its silence for the first time in 10 days after Indian drug major Ranbaxy's $500 million settlement ...Read more
Dr Samir Brahmachari: India's regulatory infrastructure needs revamp
India | Influencers | By Rahul Koul Koul | 1 Comment | 21 Nov, 2012
India's Council of Scientific and Industrial Research (CSIR) celebrated 70 years of existence this year. An organization...Read more
Dr Yusuf K Hamied: India's generics king
India | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2012
Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a co...Read more
Mr Tarun Pandotra, PRA India: Drug discovery outsourcing will gain momentum in 2013
India | Opinion | By BioSpectrum Bureau | 3 Comment | 25 Dec, 2012
The drug discovery outsourcing market will experience high revenue growth from 2013-to-2023. Expansion of the market wil...Read more
India needs awareness on IP, say experts
India | News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2012
Bangalore: "India stands one among the top 10 league of countries in the Global Innovation Efficiency Index which shows ...Read more
Actis contemplating sale of Sterling Hospitals
India | News | By BioSpectrum Bureau | 0 Comment | 06 Dec, 2013
Singapore: India based Private equity (PE) major Actis Capital is said to be considering a sale of Ahmedabad-based Sterl...Read more
Biosimilars suspension leads to monopoly in Sri Lanka
India | Analysis | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012
With the suspension of the registration of 36 similar bio-therapeutic products in Sri Lanka, the country's healthcare ma...Read more